Tickerplace logo

Tickerplace

Zenas BioPharma, Inc. logo

ZBIOZenas BioPharma, Inc.

ZBIO Stock Price, Valuation & Chart | Zenas BioPharma, Inc.

Compare
$28.230+0.15 (+0.53%)

At close · 22 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

ZBIO Historical price chart

ZBIO Key Stats

Market Capitalization1.84B
PE Ratio-3.14
EPS-8.99
Trading Volume406.01K
Today's High/Low28.83/27.51
Dividend Yield0.00
52 Week High/Low44.6/13.5
Shares Outstanding65.18M
ZBIO Financial Statement
ZBIO Analyst ratings
ZBIO Analysis & performance metrics

ZBIO Company profile

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead…

ZBIO Management team

Management
Jennifer A. FoxCFO
Chief Business Officer & Chief Financial Officer
Lisa von Moltke M.D.
Head of Research & Development and Chief Medical Officer
Caroline Chevalier
Chief Human Resources Officer
Haley Laken Ph.D.
Chief Scientific Officer
Orlando Oliveira
Chief Commercial Officer
Jeffrey Held
Chief Legal Officer
Leon Oliver Moulder Jr., M.B.A.CEO
Chief Executive Officer & Chairman of the Board
Joseph L. FarmerCOO
Chief Operating Officer & President
Total 8 executives

ZBIO Frequently asked questions

What is Zenas BioPharma, Inc. (ZBIO) Stock Price?

Current stock price of Zenas BioPharma, Inc. (ZBIO) stock is $28.230. The stock price is +0.53% higher in the session. The intraday range can be seen from this page. Volume of Zenas BioPharma, Inc. (ZBIO) stock is 406.01K.

Last updated at 22 Oct 2026, 08:00 pm.

Why is the Zenas BioPharma, Inc. (ZBIO) stock price going up or down today?

The stock price of Zenas BioPharma, Inc. (ZBIO) can change with earnings, company news, and overall market sentiment. Zenas BioPharma, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Zenas BioPharma, Inc. stock expensive at its current price?

Whether Zenas BioPharma, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ZBIO on this page is -3.14. EPS on this page is -8.99. Compare those figures with peers and growth expectations before deciding if the current Zenas BioPharma, Inc. price is justified.

How has the stock price of Zenas BioPharma, Inc. (ZBIO) performed historically?

Historical performance for Zenas BioPharma, Inc. (ZBIO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ZBIO reacted to past earnings and market events.

Should I buy Zenas BioPharma, Inc. (ZBIO) stock, at this price?

Buying Zenas BioPharma, Inc. (ZBIO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.